BayesPharma Labs
An India-first therapeutics R&D company building toward AI- and robotics-driven novel drug discovery through tighter Design → Make → Test → Learn loops.
- Drug discovery
- Scientific AI
- Robotics
- Closed-loop DMTA
- Evidence governance
I am Gunda Upendar Rao — a pharmaceutical-science-trained founder building products across drug discovery, pharmaceutical decision intelligence, educational games, and frontier science.
Current work is highlighted first without erasing the ventures that came before it. My present focus spans autonomous therapeutics R&D, pharmaceutical decision intelligence, self-directed learning, and frontier-science exploration.
An India-first therapeutics R&D company building toward AI- and robotics-driven novel drug discovery through tighter Design → Make → Test → Learn loops.
Science-first decision intelligence for pharmaceutical development, connecting models, evidence, uncertainty, governance, and next actions.
A self-directed, game-based learning platform where children play, create, publish, and learn by building.
The unified home for astronomy, mission simulations, satellite concepts, space AI, exploration, and frontier-science learning.
Earlier ventures are not discarded. They show the sequence of problems, lessons, risks, and convictions that produced the current work.
Early healthcare technology, operations, and practical founder execution.
Medicine safety, pharmaceutical trust, and healthcare-focused company building.
Scientific parks, playful STEM, educational games, story worlds, experiments, and self-directed learning.
Creator-first learning, unified frontier-science work, astrobiology exploration, and a public movement for technological optimism.
Autonomous drug-discovery R&D and pharmaceutical evidence-to-decision software: one focused on generating better therapeutic evidence, the other on connecting models, development and scientific decisions.
I trained in pharmaceutical sciences at University College of Pharmaceutical Sciences, Kakatiya University, and later at NIPER Mohali. My work has moved across pharmaceutical intelligence, research, healthcare ventures, education, games, scientific software and founder-led technology. That combination lets me move between mechanisms, models, interfaces and business questions without treating them as separate worlds.